Advertisement

Journal of Cancer Survivorship

, Volume 9, Issue 2, pp 172–179 | Cite as

Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery

  • Sigrun DahlEmail author
  • Jon Håvard Loge
  • Viktor Berge
  • Alv Andreas Dahl
  • Milada Cvancarova
  • Sophie Dorothea Fosså
Article

Abstract

Purpose

The purpose of this study is to study the influence of radical prostatectomy (RP) for prostate cancer on work status and working life in men 3 years after surgery.

Methods

In a prospective, questionnaire-based study on adverse effects after RP, 330 prostate cancer (PCa) patients who had been active in the workforce before RP described their work status 3 years after having surgery. We dichotomized their postoperative work status into “unchanged or increased” versus “reduced.” The participants also reported whether their working life was influenced by the PCa trajectory to no, some, or a great extent. Univariate and multiple logistic regression models were established with sociodemographic and clinical characteristics as independent variables and “work status” or “influence of PCa trajectory on working life” as dependent variables.

Results

Twenty-five percent of the participants had retired. Of the remaining participants, approximately 20 % had a reduced work status, which in the multivariate analyses was significantly associated with increasing age. One third of the men still active in the workforce considered the PCa to negatively influence their working life. This was independently associated with bother related to urinary leakage, fatigue, and having undergone additional oncological therapy (pelvic radiotherapy and/or hormone treatment).

Conclusion

Though RP does not affect work status in most men, approximately one third of them experience problems in their working life due to adverse effects related to RP and/or additional post-RP anti-cancer therapy.

Implications for Cancer Survivors

Most PCa survivors can expect to remain in the workforce for at least 3 years after RP, but for some, persistent adverse effects after RP and /or additional anti-cancer treatment negatively affect their working life. Pre-RP counseling of men within the workforce should cover possible post-RP changes concerning work status and working life.

Keywords

Prostate cancer Radical prostatectomy Work participation Adverse effects 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

The Norwegian Cancer Society funded the study.

References

  1. 1.
    Amir Z, Moran T, Walsh L, Iddenden R, Luker K. Return to paid work after cancer: a British experience. J Cancer Surviv. 2007;1(2):129–36.CrossRefPubMedGoogle Scholar
  2. 2.
    Spelten ER, Verbeek JHAM, Uitterhoeve ALJ, Ansink AC, van der Lelie J, de Reijke TM, et al. Cancer, fatigue and the return of patients to work—a prospective cohort study. Eur J Cancer. 2003;39(11):1562–7.CrossRefPubMedGoogle Scholar
  3. 3.
  4. 4.
    Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61.CrossRefPubMedGoogle Scholar
  5. 5.
    Stensvold A, Dahl AA, Brennhovd B, Smastuen MC, Fossa SD, Lilleby W, et al. Bother problems in prostate cancer patients after curative treatment. Urol Oncol 2012 Feb 16Google Scholar
  6. 6.
    Dahl S, Steinsvik EA, Dahl AA, Loge JH, Cvancarova M, Fossa SD. Return to work and sick leave after radical prostatectomy: a prospective clinical study. Acta Oncol 2013 Nov 6.Google Scholar
  7. 7.
    Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fossa SD. Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother. BJU Int. 2012;109(9):1366–74.CrossRefPubMedGoogle Scholar
  8. 8.
    Ilmarinen J, Tuomi K, Klockars M. Changes in the work ability of active employees over an 11-year period. Scand J Work Environ Health. 1997;23 Suppl 1:49–57.PubMedGoogle Scholar
  9. 9.
    D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969–74.CrossRefPubMedGoogle Scholar
  10. 10.
    Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273(2):129–35.CrossRefPubMedGoogle Scholar
  11. 11.
    Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905.CrossRefPubMedGoogle Scholar
  12. 12.
    Statistics Norway. Levekårsundersøkelsen 2002. 2014. Ref Type: Unpublished WorkGoogle Scholar
  13. 13.
    Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. Int Qual Life Assess J Clin Epidemiol. 1998;51(11):1171–8.Google Scholar
  14. 14.
    Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147–53.CrossRefPubMedGoogle Scholar
  15. 15.
    Nordby P, Nerland SM, Næsheim H. Yrkesaktivitet blant eldre før og etter pensjonsreformen. Statistics Norway 2014Google Scholar
  16. 16.
    Wold M.G, Håland I. Eldre i arbeidslivet. Statistics Norway 2014Google Scholar
  17. 17.
    Bradley CJ, Neumark D, Luo Z, Bednarek H, Schenk M. Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst. 2005;97(13):958–65.CrossRefPubMedGoogle Scholar
  18. 18.
    Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25(1):47–54.CrossRefPubMedGoogle Scholar
  19. 19.
    Oberst K, Bradley CJ, Gardiner JC, Schenk M, Given CW. Work task disability in employed breast and prostate cancer patients. J Cancer Surviv Res Pract. 2010;4(4):322–30.CrossRefGoogle Scholar
  20. 20.
    Mols F, Thong MS, Vreugdenhil G, van de Poll-Franse LV. Long-term cancer survivors experience work changes after diagnosis: results of a population-based study. Psychooncology. 2009;18(12):1252–60.CrossRefPubMedGoogle Scholar
  21. 21.
    Torp S, Nielsen RA, Gudbergsson SB, Fossa SD, Dahl AA. Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study. J Cancer Surviv. 2012;6(3):315–23.CrossRefPubMedGoogle Scholar
  22. 22.
    Maunsell E, Drolet M, Brisson J, Brisson C, Masse B, Deschenes L. Work situation after breast cancer: results from a population-based study. J Natl Cancer Inst. 2004;96(24):1813–22.CrossRefPubMedGoogle Scholar
  23. 23.
    Duijts S, Egmond M, Spelten E, van Muijen P, Anema J, van der Beek A. Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review. Psycho-Oncology. 2013;22:327–8.Google Scholar
  24. 24.
    Gore JL, Gollapudi K, Bergman J, Kwan L, Krupski TL, Litwin MS. Correlates of bother following treatment for clinically localized prostate cancer. J Urol. 2010;184(4):1309–15.CrossRefPubMedGoogle Scholar
  25. 25.
    Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schroder FH. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol. 2001;19(6):1619–28.PubMedGoogle Scholar
  26. 26.
    Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Chen VW, Cooperberg MR, et al. Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: defining the population at risk for harms of prostate cancer treatment. Cancer 2014 Feb 7.Google Scholar
  27. 27.
    Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int. 2006;97(1):96–100.CrossRefPubMedGoogle Scholar
  28. 28.
    Grunfeld EA, Drudge-Coates L, Rixon L, Eaton E, Cooper AF. “The only way I know how to live is to work”: a qualitative study of work following treatment for prostate cancer. Health Psychol. 2013;32(1):75–82.CrossRefPubMedGoogle Scholar
  29. 29.
    Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19(14):3385–91.PubMedGoogle Scholar
  30. 30.
    Kyrdalen AE, Dahl AA, Hernes E, Cvancarova M, Fossa SD. Fatigue in hormone-naive prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic Dis. 2010;13(2):144–50.CrossRefPubMedGoogle Scholar
  31. 31.
    Kyrdalen AE, Dahl AA, Hernes E, Hem E, Fossa SD. Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs. Prostate. 2010;70(13):1480–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Langston B, Armes J, Levy A, Tidey E, Ream E. The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature. Support Care Cancer. 2013;21(6):1761–71.CrossRefPubMedGoogle Scholar
  33. 33.
    Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.CrossRefPubMedGoogle Scholar
  34. 34.
    Iversen P, Mcleod DG, See WA, Morris T, Armstrong J, Wirth MP. Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years. BJU Int. 2010;105(8):1074–81.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Sigrun Dahl
    • 1
    Email author
  • Jon Håvard Loge
    • 1
  • Viktor Berge
    • 1
  • Alv Andreas Dahl
    • 1
  • Milada Cvancarova
    • 1
  • Sophie Dorothea Fosså
    • 1
  1. 1.The Norwegian Radium HospitalOslo University HospitalOsloNorway

Personalised recommendations